Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and Company to develop and...
Seamless Therapeutics -- Collaboration will advance a next generation gene editing approach by combining Seamless’ expertise in developing highly precise...
GP Goodwin Procter LLP More At Goodwin, we partner with our clients to practice...
-- New collaboration follows previous Lilly and Nimbus AMPK research collaboration in cardiometabolic disease -- BOSTON, January 06, 2026--(BUSINESS WIRE)--Nimbus...
Collaboration will combine Lexeo expertise in cardiac genetic medicine with Johnson & Johnson’s expertise in cardiovascular therapeutics and circulatory technologies,...
Image: Researchers from our Centre for Protein DegradationThe Institute of Cancer Research and biotechnology company NEOsphere Biotechnologies have announced a...
